Peritoneal Surface Malignancies

A Curative Approach
1. Auflage 2015
ISBN: 978-3-319-12936-5
Verlag: Springer International Publishing

Buch, Englisch, 109 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 4323 g

This book has been designed to provide the full description of the comprehensive management of peritoneal surface malignancies as a new emerging specialty. Combined treatment of cytoreductive surgery (CRS) and hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) introduced by our leader Paul H. Sugarbaker are performed to treat peritoneal metastases by surgeons all around the world. Therefore this book is focused on detailed surgical anatomy of the peritoneum, preoperative clinical assessment of the peritoneal surface malignancy, patient preparation and operation room equipments, different surgical procedures for CRS and reconstruction, intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) and neoadjuvant intraperitoneal chemotherapy, early postoperative intraperitoneal chemotherapy (EPIC) and molecular basis of peritoneal surface malignancies.

The chapter on molecular mechanisms of the formation of peritoneal carcinomatosis provides insight into a rapidly expanding knowledge within this speciality.

This book should be valuable for surgical oncologists who deal with multimodal treatment for peritoneal surface malignancies, as well as for the trained peritonectomy surgeons. For the senior surgeons, it will also introduce new techniques and approaches in this field such as dealing with the omental cakes and massive organ involvement that requires multi-organ resection.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Yonemura, Yutaka

Canbay, Emel

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

1. Anatomy of Peritoneum and Preoperative Assessment of Patients with Peritoneal Surface Malignancies.- 2. Surgical Technique for Cytoreductive Surgery.- 3. Intraperitoneal Chemotherapy Applications.- 4. Management of Special Issues.- 5.  Molecular Mechanism of Peritoneal Metastases.

Über Autor(innen)

Emel Canbay has a MD from Cumhuriyet University (Turkey) and PhD University of London King's College School of Medicine and Dentistry (UK). She has had fellowships from the University of Bristol (UK); the International Centre for Genetic Engineering and Biotechnology (Italy); and Imperial Cancer Research Fund (London, UK). She has a speciality in General Surgery from Ankara, Turkey. She has been assigned from the Ministry of Health of Turkey as an attending surgeon to the Breast Units and Gastrointestinal Surgery, and Accident and Emergency Departments of Istanbul University, Istanbul Medical Faculty and Istanbul Cerrahpasa Medical Faculty for four years. She had a clinical fellowship from Peritoneal Cancer Centre in Osaka- Japan under the supervision of Dr. Yutaka Yonemura. She has been completed surgical and clinical follow up over the 200 cases with peritoneal metastases in Japan. She has been working as Head of the Peritoneal Malignancy Centre and Non Profit Organization for Hyperthermic Intraperitoneal Chemotherapy (Istanbul, Turkey )since 2013.